Source: BMC cancer [BMC Cancer] 2024 Mar 29; Vol. 24 (1), pp. 397. Date of Electronic Publication: 2024 Mar 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial.

Authors : van Dam JL; Verkolf EMM ...

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/surgery

Source: BMC cancer [BMC Cancer] 2023 Aug 07; Vol. 23 (1), pp. 728. Date of Electronic Publication: 2023 Aug 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Individualized number of induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma patients based on early tumor response.

Authors : Jiang YT; Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.; Chen KH

Subjects: Induction Chemotherapy*/Induction Chemotherapy*/Induction Chemotherapy*/methods ; Nasopharyngeal Neoplasms*/Nasopharyngeal Neoplasms*/Nasopharyngeal Neoplasms*/pathology; Humans

Source: Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (4), pp. 4010-4022. Date of Electronic Publication: 2022 Sep 20.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation.

Authors : Jun M; Stanford Cancer Institute, Stanford University, Stanford, California, United States of America.; Pinto H

Subjects: Induction Chemotherapy*/Induction Chemotherapy*/Induction Chemotherapy*/methods ; Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/Nasopharyngeal Carcinoma*/drug therapy ; Nasopharyngeal Neoplasms*/Nasopharyngeal Neoplasms*/Nasopharyngeal Neoplasms*/drug therapy

Source: PloS one [PLoS One] 2023 Feb 02; Vol. 18 (2), pp. e0276651. Date of Electronic Publication: 2023 Feb 02 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Adjuvant 5-Fluorouracil/leucovorin, capecitabine, and oxaliplatin-related regimens for stage II/III colon cancer patients 66 years or older.

Authors : Jones E; Department of Biostatistics, The University of Texas School of Public Health at Houston, Houston, Texas, USA.; Duan Z

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/pathology; Humans

Source: Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 2389-2406. Date of Electronic Publication: 2022 Oct 13.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Real World Presentation and Treatment Outcomes with a Predominant Induction Chemotherapy Based Approach in Nasopharyngeal Carcinoma: A Sixteen Year Report from a Teaching Hospital in India.

Authors : Gogi R; Department of Medical Oncology, Dr. B.R.A. IRCH, All India Institute of Medical Sciences, New Delhi, India.; Sharma A

Subjects: Induction Chemotherapy* ; Nasopharyngeal Neoplasms*/Nasopharyngeal Neoplasms*/Nasopharyngeal Neoplasms*/drug therapy ; Nasopharyngeal Neoplasms*/Nasopharyngeal Neoplasms*/Nasopharyngeal Neoplasms*/pathology

Source: Cancer investigation [Cancer Invest] 2023 Feb; Vol. 41 (2), pp. 155-163. Date of Electronic Publication: 2022 Nov 17.Publisher: Taylor & Francis Country of Publication: England NLM ID: 8307154 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC.

Authors : Roth L; Surgical Oncology Research Laboratory, Department of Surgery & Transplantation, University Hospital of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.; Eshmuminov D

Subjects: Cytoreduction Surgical Procedures*/Cytoreduction Surgical Procedures*/Cytoreduction Surgical Procedures*/adverse effects ; Hyperthermia, Induced*/Hyperthermia, Induced*/Hyperthermia, Induced*/methods ; Hyperthermic Intraperitoneal Chemotherapy*/Hyperthermic Intraperitoneal Chemotherapy*/Hyperthermic Intraperitoneal Chemotherapy*/adverse effects

Source: World journal of surgical oncology [World J Surg Oncol] 2023 Jan 12; Vol. 21 (1), pp. 5. Date of Electronic Publication: 2023 Jan 12.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review.

Authors : Gebremariam GT; School of Pharmacy, Addis Ababa University, Zambia Street, P.O. box: 1176, Addis Ababa, Ethiopia. .; Fentie AM

Subjects: Chemotherapy-Induced Febrile Neutropenia*/Chemotherapy-Induced Febrile Neutropenia*/Chemotherapy-Induced Febrile Neutropenia*/drug therapy ; Chemotherapy-Induced Febrile Neutropenia*/Chemotherapy-Induced Febrile Neutropenia*/Chemotherapy-Induced Febrile Neutropenia*/etiology ; Chemotherapy-Induced Febrile Neutropenia*/Chemotherapy-Induced Febrile Neutropenia*/Chemotherapy-Induced Febrile Neutropenia*/prevention & control

Source: BMC health services research [BMC Health Serv Res] 2022 Dec 30; Vol. 22 (1), pp. 1600. Date of Electronic Publication: 2022 Dec 30.Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Consolidation Chemotherapy Rather than Induction Chemotherapy Can Prolong the Survival Rate of Inoperable Esophageal Cancer Patients Who Received Concurrent Chemoradiotherapy.

Authors : Xia X; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.; Wu M

Subjects: Consolidation Chemotherapy* ; Esophageal Neoplasms*/Esophageal Neoplasms*/Esophageal Neoplasms*/drug therapy; Chemoradiotherapy

Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Sep 02; Vol. 29 (9), pp. 6342-6349. Date of Electronic Publication: 2022 Sep 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer.

Authors : Kappel C; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.; Elliott MJ

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy; Female

Source: Scientific reports [Sci Rep] 2024 Feb 07; Vol. 14 (1), pp. 3129. Date of Electronic Publication: 2024 Feb 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي